Discount Code (0% Off) has been applied.
Make a Selection
(0) items
You have no items in your shopping cart.
Browse by Category
    Manufacturers: International , Pfizer

    Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis − e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself. Vigorous bicarbonate therapy is required in any form of metabolic acidosis where a rapid increase in plasma total CO2 content is crucial − e.g., cardiac arrest, circulatory insufficiency due to shock or severe dehydration, and in severe primary lactic acidosis or severe diabetic acidosis.

    Manufacturer: International

    Sodium Bicarbonate, 8.4%, 50mEq, Luer-Jet L/L 50mL Syringe

    Availability: Out of stock
    $16.47
    Item Code: 003448
    Mfg Part #: 76329-3352-01
    This product requires a verified medical license to purchase.
    Select your shipping method. This is helpful to expedite a portion of your order.
      Usually ships within 24 hours.

    Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis − e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself. Vigorous bicarbonate therapy is required in any form of metabolic acidosis where a rapid increase in plasma total CO2 content is crucial − e.g., cardiac arrest, circulatory insufficiency due to shock or severe dehydration, and in severe primary lactic acidosis or severe diabetic acidosis.

    Products specifications
    Class Rx
    Medical License Required Yes
    Form SDV
    Generic Name Sodium Bicarbonate
    Preservative No
    Size 50 mL
    Strength 8.4%, 84 mg/mL
    Therapeutic Class Alkalizing Agents
    Products specifications
    Manufacturer: Hospira

    Sodium Bicarbonate 8.4%, 50mEq/vial, SDV, 50mL Vial

    $13.99
    Quantity Discounts:
    Purchase Qty. Price You Save
    25+ $13.49
    Item Code: 000971
    Mfg Part #: 00409-6625-02
    This product requires a verified medical license to purchase.
    Select your shipping method. This is helpful to expedite a portion of your order.
      Usually ships within 24 hours.

    Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis − e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself. Vigorous bicarbonate therapy is required in any form of metabolic acidosis where a rapid increase in plasma total CO2 content is crucial − e.g., cardiac arrest, circulatory insufficiency due to shock or severe dehydration, and in severe primary lactic acidosis or severe diabetic acidosis.

    Products specifications
    Class Rx
    Medical License Required Yes
    Form SDV
    Generic Name Sodium Bicarbonate
    Preservative No
    Size 50 mL
    Strength 8.4%, 84 mg/mL
    Therapeutic Class Alkalizing Agents
    Products specifications
    Products specifications
    Class Rx
    Medical License Required Yes
    Form SDV
    Generic Name Sodium Bicarbonate
    Preservative No
    Size 50 mL
    Strength 8.4%, 84 mg/mL
    Therapeutic Class Alkalizing Agents

    Coronavirus (COVID-19)

    Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

    In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

    Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

    As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

    Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President